Drug Development in the 21st Century

NICE: It Takes Two to Tango

What’s New from the 2016 ESMO Clinical Guidelines

Update to the “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors”

National Comprehensive Cancer Network NSCLC Guideline Updates for 2016: Non-Small Cell Lung Cancer

Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030

COVID-19 and Lung Cancer

Renowned Medical Oncologist, Investigator to Take Reins at IASLC in March

The Art and Science of Patient–Doctor Communication

Introducing the New ILCN

In Brief for February 9, 2022

Multidisciplinary Tumor Boards: Six Eyes See More than Two